文献速递免疫规划

表达猫杯状病毒VP1蛋白的重组猫疱疹病毒1型在猫中安全有效

The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats.
PubMed 文献 · Vaccine · 2024-10-29

研究以猫疱疹病毒1型WX19株为亲本,删除gI/gE基因并表达猫杯状病毒VP1蛋白,构建重组株FHV ΔgI/gE-FCV VP1。猫经鼻接种1 mL含10^6 TCID50该重组株,第28天完成接种后用强毒FCV攻毒,结果所有接种安全,临床疾病评分、病理变化和鼻腔排毒显著降低,并诱导了强劲免疫反应。

要点

  • 重组株FHV ΔgI/gE-FCV VP1在CRFK细胞中表达FCV VP1并形成病毒样颗粒。
  • 猫经鼻接种1 mL含10^6 TCID50重组株,所有接种均判定为安全。
  • 攻毒后临床疾病评分、病理变化和鼻腔排毒显著降低,并诱导强劲免疫反应。

核心结论

  • 这些发现共同表明基于FHV的重组疫苗在预防FCV感染方面有效。

研究设计与样本

  • 以FHV WX19株为亲本,删除gI/gE基因并同时表达FCV VP1,构建重组株FHV ΔgI/gE-FCV VP1。
  • 猫经鼻接种1 mL含10^6 TCID50的FHV ΔgI/gE-FCV VP1,第28天完成接种后用强毒FCV攻毒。

主要发现

  • 蛋白印迹和免疫荧光试验证实FHV ΔgI/gE-FCV VP1感染的CRFK细胞中存在FCV VP1,透射电镜观察到FCV病毒样颗粒。
  • 所有FHV ΔgI/gE-FCV VP1接种均判定为安全,感染后临床疾病评分、病理变化和病毒鼻腔排毒显著降低,并诱导强劲免疫反应。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Feline herpesvirus type 1 (FHV) and feline calicivirus (FCV) are significant pathogens causing upper respiratory tract disease in cats. Existing inactivated or modified live vaccines against FCV and FHV face limitations in safety and efficacy. To overcome these challenges, a recombinant strain FHV ΔgI/gE-FCV VP1 was developed by deleting the gI/gE gene and concurrently expressing FCV VP1, using the FHV WX19 strain as the parental virus. Results indicated the presence of FCV VP1 in FHV ΔgI/gE-FCV VP1-infected CRFK cells, confirmed through protein blotting and immunofluorescence assays and virus-like particles (VLPs) of FCV were observed using transmission electron microscopy. For efficacy in cats, each animal received intranasal vaccination with 1 mL of FHV ΔgI/gE-FCV VP1 at 106 TCID50. Following completion of vaccination on day 28, animals were exposed to a potent FCV strain. Assessments included clinical signs, nasal shedding, virus neutralizing antibodies, cytokine expression and postmortem histological testing. All vaccinations with FHV ΔgI/gE-FCV VP1 were deemed safe, with significantly reduced clinical disease scores, pathological changes and viral nasal shedding following infection and robust immune responses were induced. These findings collectively suggest the effectiveness of FHV-based recombinant vaccines in preventing FCV infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tang A, Zhu M, Zhu J, et al. The recombinant feline herpesvirus 1 expressing feline Calicivirus VP1 protein is safe and effective in cats. Vaccine. 2024. PMID: 39467408. doi:10.1016/j.vaccine.2024.126468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。